Check the current and upcoming studies to get in touch!

 

Explore opportunities to participate in current and upcoming medical studies by consulting our complete list. Get in touch with our team today to join our innovative research and help shape the future of healthcare.

Clinic of
Val-Bélair

Telephone  (418) 847-1112
Fax  (418) 847-9134
See the Clinic page
z
Clinic of
Lebourgneuf

Telephone  (418) 704-1112
Fax  (418) 704-1092
See the Clinic page
z
Clinic of
Lévis

Telephone  (418) 380-1112
Fax  (418) 603-6969
See the Clinic page
z

Our studies

Select the current or upcoming studies according to your center of preference

Migraines

Adolescents with migraines

Men
Women
12-17 years
Tablets
Compensation for travel expenses

Diabetes

Adults with type 2 diabetes

Men
Women
18 years and over
Subcutaneous injection
Compensation for travel expenses

Alzheimer’s disease

Adults with moderate Alzheimer’s disease

Men
Women
60-85 years
Tablets
Compensation for travel expenses

Alzheimer’s disease

Adults with early symptomatic Alzheimer’s disease

Men
Women
50-90 years
Intravenous (IV)
Compensation for travel expenses

Older adults at risk of malnutrition

Men
Women
60-90 years
Tablets
Compensation for travel expenses

Prevention of heart disease

Men
Women
18 years and over
Subcutaneous injection
Compensation for travel expenses

Prevention of heart disease

Men
Women
18 years and older
Tablets
Compensation for travel expenses

Allergic rhinitis

Men
Women
18 years and over
Subcutaneous injection
Compensation for travel expenses

Depression

Men
Women
18-75 years
Tablets
Compensation for travel expenses

Stress urinary incontinence

with obesity or excess weight

Men
Women
18 years and over
Tablets
Compensation for travel expenses

Alzheimer

Adults with early symptomatic Alzheimer's disease.

Men
Women
50-80 years
Subcutaneous injection
Compensation for completing questionnaires

Obesity/overweight with knee osteoarthritis

Men
Women
18 years and over
Tablets
Compensation for travel expenses

Diabetes

Adults with type 2 diabetes

Men
Women
18 years and over
Subcutaneous injection
Compensation For travel expenses

Chronic sinusitis with nasal polyps

Men
Women
18 years and over
Subcutaneous injection
Compensation for travel expenses

Chronic sinusitis without nasal polyps

Men
Women
18 years and over
Subcutaneous injection
Compensation for travel expenses

Older adults at risk of malnutrition

Men
Women
60-90 years
Tablets
Compensation for travel expenses

Diabetes

Men
Women
18 years and over
Subcutaneous injection
Compensation for travel expenses

Alzheimer’s disease with agitation

Men
Women
55-90 years
Tablets
Compensation for travel expenses

Depression

Men
Women
18-75 years
Subcutaneous injection
Compensation for travel expenses

Stress urinary incontinence

with obesity or overweight

Men
Women
18 years and over
Tablets
Compensation for travel expenses

COPD

Men
Women
40-80 years
Subcutaneous injection
Compensation for travel expenses

Allergic rhinitis

Men
Women
18 years and over
Subcutaneous injection
Compensation for travel expenses

Study approach

Personalized support

Our team of healthcare professionals stands out for its humane and respectful approach.

alpha-recherche-clinique_pour-les-commanditaires-detude_notre-materiel-et-nos-equipements-perfusion-intraveineuse 01

The first meeting and consent.

During the first visit you will meet with one of the study’s research coordinators. This meeting always begins with the reading of consent where you will have the opportunity to ask your questions. If you agree to participate in the study, you will be asked to sign the consent.

DSC_3090-min 02

The selection period

Once the consent has been signed, the research coordinator will ask you some questions in order to know your medical history. Each search protocol is unique and has a list of inclusion and exclusion criteria. She will also perform some of the procedures required by the protocol. Here are some examples (vital signs, electrocardiogram and blood tests). This data will help assess whether you are potentially eligible for the study. The interventions performed and the duration of this period is unique to each study.

alpha-recherche-clinique_specialisation-en-recherche-clinique-a-quebec 03

Randomization

If you meet all the criteria for the study, you will be able to be randomized, which means you will be able to start the study medication.

alpha-recherche-clinique_nos-etudes_consulter-nos-etudes-en-cours_participer-a-une-autre-etude 04

Treatment phase

During this phase, you receive study medication. There will also be follow-up clinic visits. Some studies also include telephone visits. The coordinator will assess your health by asking you a few questions and collect some data by performing some of the interventions required by the study protocol.

suivi fin de traitement 05

The end of treatment follow-up.

This phase begins when you complete study treatment. The duration and number of visits vary depending on the protocol, but it usually consists of an additional visit approximately 2 to 4 weeks after stopping treatment. The follow-up allows to conclude the study safely. If additional testing is required, the coordinator will contact the medical investigator for additional testing.

Latest news

Expand your knowledge

 

Explore the crucial discoveries of clinical research through our blog posts, offering a serious look at medical advances, illuminating your understanding and stimulating your commitment to health and wellness.

What is obesity?

What is asthma?

What is diabetes?

What is Alzheimer's disease?

Gérer le consentement